PFE Jan 2024 65.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:26PM EST. Market open.
| Previous close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0000 |
| Ask | 0.0100 |
| Strike | 65.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0100 - 0.0100 |
| Contract range | N/A |
| Volume | |
| Open interest | 5.44k |
ZacksPfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study
Interim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast cancer combination therapy demonstrates encouraging clinical activity in heavily pre-treated patients.
LA TimesColumn: A bogus new attack on COVID vaccines from Texas' least credible politician
Texas Attorney General Ken Paxton unveils a fact-free lawsuit questioning Pfizer's COVID vaccine, which has helped to save millions of people from hospitalization and death.
ZacksRoche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Roche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation achieves its primary goal.
© 2023 Yahoo. All rights reserved.